Xaira Therapeutics

Overview

Xaira Therapeutics builds an AI-powered drug discovery and development platform to decode disease, design therapies, and support end-to-end medicine creation for patients.

Part of the Silicon Valley ecosystem

Related

• 8VC8VC invests in technology businesses across healthcare, life sciences, manufacturing, logistics, and defense, and builds new companies when existing firms do not address selected opportunities.
• a16z Bio + Healtha16z Bio + Health invests in and supports biotechnology and healthcare founders developing medicines, diagnostics, care delivery models, provider tools, and healthcare infrastructure.
• Chai DiscoveryChai Discovery develops AI-based computer-aided molecule design tools used in drug discovery programs, including antibody discovery collaborations with pharmaceutical companies.
• DCVCDCVC is a deep tech venture capital firm backing entrepreneurs applying AI and other advanced technologies to problems across sectors such as computing, bio, climate, defense, agriculture, and manufacturing.
• In-Q-TelIn-Q-Tel builds a nonprofit investment platform that identifies strategic technology startups and adapts their technologies to meet current and future government partner mission needs.
• insitroinsitro combines automated cellular experiments, population genetics, and AI models to identify causal disease targets and design therapeutics for human disease drug discovery.
• MedraMedra builds an AI-driven autonomous robotic platform that executes laboratory protocols and integrates instruments and software to automate experimental workflows for life-science labs and research teams.
• Merge LabsMerge Labs collect visitor inquiries and email list sign-ups through a launch landing page, enabling updates, promotions, and direct contact before the site opens.
• NewLimitNewLimit develops medicines using AI-designed payloads and genomics testing to restore youthful function in old cells, targeting age-related cellular decline and human healthspan.
• Numerion LabsNumerion Labs builds an AI platform that searches chemical space for novel drug-like molecules, supporting small-molecule drug discovery programs for immune and inflammatory diseases.
• ProfluentProfluent builds AI systems that design proteins from natural scaffolds or from scratch for therapeutic, industrial enzyme, and other protein design applications.
• Stanford UniversityStanford University educates undergraduate and graduate students, conducts broad basic and applied research across disciplines, and provides clinical care, community programs, and scholarly communication.

Timeline

1. Aug 2025Funding Roundbloomberg.com ↗

   Series A extension; AI protein design (David Baker spinout).